CLRB
NASDAQ
US
Cellectar Biosciences, Inc. - Common Stock
$2.55
▲ +$0.05
(+2.00%)
Vol 31K
2
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$12.5M
ROE
-177.5%
Margin
-24744.4%
D/E
0.00
Beta
0.30
52W
$2–$21
Wall Street Consensus
9 analysts · Apr 20263
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
77.8%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%
Next Report
May 11, 2026
EPS Estimate: $-1.71
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-1.71 | — | — |
| Dec 2025 | $-2.34 | $-1.29 | +$1.05 |
| Sep 2025 | $-2.58 | $-1.41 | +$1.17 |
| Jun 2025 | $-3.98 | $-3.39 | +$0.59 |
Quarterly Revenue & Earnings
| Quarter | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Net Income | — | -$2.4M | -$6.6M | -$5.4M | -$4.4M | -$5.3M |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | -234.8% | -176.5% | -235.8% | -235.8% | -235.8% | -177.5% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -24744.4% | -24744.4% | -24744.4% | -24744.4% | -24744.4% |
| Gross Margin | — | — | — | — | — | — |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 2.15 | 2.47 | 2.15 | 2.15 | 2.15 | 2.77 |
Key Ratios
ROA (TTM)
-108.7%
P/S (TTM)
138.98
P/B
0.8
EPS (TTM)
$-10.78
CF/Share
$-3.44
52W High
$20.59
52W Low
$2.45
$2.45
52-Week Range
$20.59
Financial Health
Free Cash Flow
-$4.4M
Net Debt
-$12.8M
Cash
$13.2M
Total Debt
$410K
As of Dec 31, 2025
How does CLRB compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
CLRB valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
139.0
▲
982%
above
peers
(12.9)
vs Peers
vs Industry
Pricier
P/B ratio
0.8
▼
68%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
CLRB profitability vs Biotechnology peers
ROE
-177.5%
▼
164%
below
peers
(-67.3%)
vs Peers
vs Industry
Weak
Net margin
-24744.4%
▼
8529%
below
peers
(-286.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(78.6%)
vs Peers
vs Industry
In line
ROA
-108.7%
▼
133%
below
peers
(-46.7%)
vs Peers
vs Industry
Weak
CLRB financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
2.8
▼
38%
below
peers
(4.4)
vs Peers
vs Industry
Low liquidity
Beta
0.3
▼
69%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
CLRB fundamentals radar
CLRB
Peer median
Industry
CLRB profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
CLRB vs peers: key metrics
Top Holders
Top 5: 6.81%Bleichroeder LP
2.36%
$270K
Vanguard Group Inc
2.10%
$241K
DRW Securities, LLC
1.07%
$122K
Geode Capital Management, L…
0.68%
$77K
Sequoia Financial Advisors,…
0.60%
$68K
As of Dec 31, 2025
Latest News
No related news yet